Recommendations for the nomenclature of enteroviruses and rhinoviruses.


Journal

Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 26 1 2020
medline: 23 2 2020
entrez: 26 1 2020
Statut: ppublish

Résumé

Enteroviruses (EVs) and rhinoviruses (RVs) are significant pathogens of humans and are the subject of intensive clinical and epidemiological research and public health measures, notably in the eradication of poliovirus and in the investigation and control of emerging pathogenic EV types worldwide. EVs and RVs are highly diverse in their antigenic properties, tissue tropism, disease associations and evolutionary relationships, but the latter often conflict with previously developed biologically defined terms, such as "coxsackieviruses", "polioviruses" and "echoviruses", which were used before their genetic interrelationships were understood. This has created widespread formatting problems and inconsistencies in the nomenclature for EV and RV types and species in the literature and public databases. As members of the International Committee for Taxonomy of Viruses (ICTV) Picornaviridae Study Group, we describe the correct use of taxon names for these viruses and have produced a series of recommendations for the nomenclature of EV and RV types and their abbreviations. We believe their adoption will promote greater clarity and consistency in the terminology used in the scientific and medical literature. The recommendations will additionally provide a useful reference guide for journals, other publications and public databases seeking to use standardised terms for the growing multitude of enteroviruses and rhinoviruses described worldwide.

Identifiants

pubmed: 31980941
doi: 10.1007/s00705-019-04520-6
pii: 10.1007/s00705-019-04520-6
pmc: PMC7024059
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-797

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI104317
Pays : United States
Organisme : Wellcome Trust
ID : ISSF204826/Z/16/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Intervirology. 1974;4(6):369-70
pubmed: 4377266
J Gen Virol. 2017 Oct;98(10):2421-2422
pubmed: 28884666
J Gen Virol. 2013 Aug;94(Pt 8):1791-1806
pubmed: 23677786
J Virol. 1990 Mar;64(3):1117-23
pubmed: 2154596
Am J Epidemiol. 1967 Mar;85(2):297-310
pubmed: 4960233

Auteurs

P Simmonds (P)

Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK. Peter.Simmonds@ndm.ox.ac.uk.

A E Gorbalenya (AE)

Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.

H Harvala (H)

National Microbiology Service, NHS Blood and Transplant, London, UK.

T Hovi (T)

Finnish Institute for Health and Welfare, Helsinki, Finland.

N J Knowles (NJ)

The Pirbright Institute, Pirbright, Woking, UK.

A M Lindberg (AM)

Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.

M S Oberste (MS)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

A C Palmenberg (AC)

Department of Biochemistry, Institute for Molecular Virology, Madison, WI, USA.

G Reuter (G)

Department of Medical Microbiology and Immunology, Medical School, University of Pécs, Pecs, Hungary.

T Skern (T)

Max Perutz Labs, Medical University of Vienna, Vienna, Austria.

C Tapparel (C)

Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

K C Wolthers (KC)

Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

P C Y Woo (PCY)

Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.

R Zell (R)

Division of Experimental Virology, Institute of Medical Microbiology, Jena University Hospital, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH